Login
← Go Back
Aarti Pharmalabs
AARTIPHARM · Pharma > Pharmaceuticals & Drugs Listing date: Jan. 30, 2023
Stock Price vs Company Growth
1d
1.1%
1w
4.5%
1m
13.8%
3m
4.8%
6m
22.0%
1y
9.2%
all
21.8%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 686 1.1%
671
817
Company Overview
Sales
1,801 Cr
Growth: -5.3%
Profit after Tax
214 Cr
Growth: -10.9%
Small Cap
6,217 Cr
P/E: 28.9x
Industry P/E: 27.8x
Fundamentals
Sales (Cr) ₹ 1,801
Growth -5.3%
EBITDA 23.2%
P/S 3.4x
Dividend 0.5%
P/E 28.9x
Book Value ₹ 233
PEG Ratio -5.4x
ROE 10.4%
P/B 2.9x
Shareholding Pattern
Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed
The company is an, internationally recognised manufacturer of Active Pharmaceutical Ingredients (API), pharmaceutical intermediates, New Chemical Entities (NCE), and xanthine derivatives situated in India. In order to build a sustainable future, it integrates process chemistry proficiency (recipe focus) with scale-up engineering proficiency (asset utilisation).
Belongs to (11 Indices) view more
Investors (14)
arti.raj...
hetal.go...
hetal.go...
Followers (1)
varsha96